Last updated on March 2018

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy


Brief description of study

The purpose of the study is to evaluate the more efficient dose for the treatment of rhinitis/rhinoconjunctivitis against grass pollen allergy

Detailed Study Description

Double blind placebo-controlled study. The subjects will receive medication during 4 months.

Clinical Study Identifier: NCT02654223

Contact Investigators or Research Sites near you

Start Over

Pedro Ojeda, PhD; MD

Hospital Universitario de Getafe
Getafe, Spain
  Connect »

Matilde Rodríguez, MD

Hospital Universitario Puerta de Hierro
Majadahonda, Spain
  Connect »

Javier Ruiz Hornillos, MD

Hospital Universitario Infanta Elena
Valdemoro, Spain
  Connect »

Javier Subiza, MD

CL NICA Dr. SUBIZA
Madrid, Spain
  Connect »

Pedro Ojeda, MD

Cl nica Ojeda
Madrid, Spain
  Connect »

Carmen Diéguez, MD

HOSPITAL UNIVERSITARIO 12 de OCTUBRE
Madrid, Spain
  Connect »

Pedro Ojeda, PhD; MD

Hospital Universitario Pr ncipe de Asturias
Alcalá de Henares, Spain
  Connect »

Antonio Moreno

Cl nica Atlas
Aranjuez, Spain
  Connect »

Amparo Conde

Hospital Nisa Aljarafe
Castilleja De La Cuesta, Spain
  Connect »

Alberto Caso

Hospital San Agust n
Dos Hermanas, Spain
  Connect »

Emilio Solano, MD

Hospital Universitario Ram n y Cajal
Madrid, Spain
  Connect »

Pedro Guardia, Dr

Hospital Universitario Virgen Macarena
Sevilla, Spain
  Connect »

Pedro Ojeda, PhD; MD

Hospital Viamed Santa Angola de la Cruz
Sevilla, Spain
  Connect »

Alicia Alonso

Cl nica Alianza M dica
Valladolid, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.